Cargando…
miR-665 targets c-MYC and HDAC8 to inhibit murine neuroblastoma cell growth
Neuroblastoma is a common tumor of the peripheral nervous system in children. Highly aggressive MYC-driven neuroblastoma is defined by increased c-MYC and/or MYCN expression. This study employed a mouse neuroblastoma cell model to assess the role of miR-665 in tumorigenesis. We found that miR-665 su...
Autor principal: | Prashad, Nagindra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6145696/ https://www.ncbi.nlm.nih.gov/pubmed/30237861 http://dx.doi.org/10.18632/oncotarget.26046 |
Ejemplares similares
-
Hsa-miR-665 Is a Promising Biomarker in Cancer Prognosis
por: Guan, Xuefeng, et al.
Publicado: (2023) -
MYCN and HDAC2 cooperate to repress miR-183 signaling in neuroblastoma
por: Lodrini, Marco, et al.
Publicado: (2013) -
Long non-coding RNA NHEG1/hsa-miR-665/HMGB1 axis is involved in the regulation of neuroblastoma progression
por: Zhang, Yuqing, et al.
Publicado: (2021) -
Sevoflurane Inhibits Metastasis in Hepatocellular Carcinoma by
Inhibiting MiR-665-Induced Activation of the ERK/MMP Pathway
por: Zhu, Xiaoyan, et al.
Publicado: (2022) -
LINC00565 promotes proliferation and inhibits apoptosis of gastric cancer by targeting miR-665/AKT3 axis
por: Hu, Jianghong, et al.
Publicado: (2019)